RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
TransGenic Group Stock

TransGenic Group ROA 2025

TransGenic Group ROA

0

Ticker

2342.T

ISIN

JP3635720000

In 2025, TransGenic Group's return on assets (ROA) was 0, a -101.08% increase from the -0.04 ROA in the previous year.

TransGenic Group Aktienanalyse

What does TransGenic Group do?

TransGenic Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding TransGenic Group's Return on Assets (ROA)

TransGenic Group's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing TransGenic Group's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider TransGenic Group's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in TransGenic Group’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about TransGenic Group stock

What is the Return on Assets (ROA) of TransGenic Group this year?

The Return on Assets (ROA) of TransGenic Group is 0 undefined this year.

What was the ROA of TransGenic Group compared to the previous year?

The ROA of TransGenic Group has increased by -101.08% compared to the previous year.

What consequences do high ROA have for investors of TransGenic Group?

A high ROA is advantageous for investors of TransGenic Group, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in TransGenic Group?

A low ROA can be unfavorable for investors of TransGenic Group as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of TransGenic Group affect the company?

An increase in ROA of TransGenic Group can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of TransGenic Group impact the company?

A reduction in the ROA of TransGenic Group can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of TransGenic Group?

Some factors that can influence the ROA of TransGenic Group include revenue, operating costs, asset structure, and industry average.

Why is the ROA of TransGenic Group important for investors?

The ROA of TransGenic Group is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can TransGenic Group take to improve ROA?

To improve ROA, TransGenic Group can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does TransGenic Group pay?

Over the past 12 months, TransGenic Group paid a dividend of 3 JPY . This corresponds to a dividend yield of about 1.71 %. For the coming 12 months, TransGenic Group is expected to pay a dividend of 3 JPY.

What is the dividend yield of TransGenic Group?

The current dividend yield of TransGenic Group is 1.71 %.

When does TransGenic Group pay dividends?

TransGenic Group pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of TransGenic Group?

TransGenic Group paid dividends every year for the past 4 years.

What is the dividend of TransGenic Group?

For the upcoming 12 months, dividends amounting to 3 JPY are expected. This corresponds to a dividend yield of 1.71 %.

In which sector is TransGenic Group located?

TransGenic Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von TransGenic Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of TransGenic Group from 6/1/2025 amounting to 3 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2025.

When did TransGenic Group pay the last dividend?

The last dividend was paid out on 6/1/2025.

What was the dividend of TransGenic Group in the year 2024?

In the year 2024, TransGenic Group distributed 3 JPY as dividends.

In which currency does TransGenic Group pay out the dividend?

The dividends of TransGenic Group are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von TransGenic Group

Our stock analysis for TransGenic Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of TransGenic Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.